SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'ERM'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y00_A_Y00A601_1 (BETA-1 ADRENERGICRECEPTOR) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 7 / 12 | TRP A 131ASP A 135VAL A 136PHE A 340PHE A 341ASN A 344TYR A 370 | NoneERM A2001 (-3.2A)ERM A2001 (-3.8A)ERM A2001 (-4.3A)NoneERM A2001 (-4.3A)ERM A2001 ( 4.8A) | 0.62A | 2y00A-4ib4A:27.8 | 2y00A-4ib4A:28.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y00_B_Y00B601_1 (BETA-1 ADRENERGICRECEPTOR) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 7 / 12 | TRP A 131ASP A 135VAL A 136PHE A 340PHE A 341ASN A 344TYR A 370 | NoneERM A2001 (-3.2A)ERM A2001 (-3.8A)ERM A2001 (-4.3A)NoneERM A2001 (-4.3A)ERM A2001 ( 4.8A) | 0.67A | 2y00B-4ib4A:27.9 | 2y00B-4ib4A:28.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y01_A_Y00A601_1 (BETA-1 ADRENERGICRECEPTOR) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 7 / 12 | TRP A 131ASP A 135PHE A 340PHE A 341ASN A 344TRP A 367TYR A 370 | NoneERM A2001 (-3.2A)ERM A2001 (-4.3A)NoneERM A2001 (-4.3A)NoneERM A2001 ( 4.8A) | 0.63A | 2y01A-4ib4A:27.7 | 2y01A-4ib4A:28.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y01_A_Y00A601_1 (BETA-1 ADRENERGICRECEPTOR) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 5 / 12 | TRP A 131ASP A 135SER A 222TRP A 367TYR A 370 | NoneERM A2001 (-3.2A)ERM A2001 ( 4.6A)NoneERM A2001 ( 4.8A) | 1.28A | 2y01A-4ib4A:27.7 | 2y01A-4ib4A:28.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y01_B_Y00B601_1 (BETA-1 ADRENERGICRECEPTOR) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 7 / 12 | TRP A 131ASP A 135VAL A 136PHE A 340PHE A 341ASN A 344TYR A 370 | NoneERM A2001 (-3.2A)ERM A2001 (-3.8A)ERM A2001 (-4.3A)NoneERM A2001 (-4.3A)ERM A2001 ( 4.8A) | 0.63A | 2y01B-4ib4A:27.9 | 2y01B-4ib4A:28.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y03_A_5FWA601_1 (BETA-1 ADRENERGICRECEPTOR) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 7 / 12 | TRP A 131ASP A 135VAL A 136PHE A 340PHE A 341ASN A 344TYR A 370 | NoneERM A2001 (-3.2A)ERM A2001 (-3.8A)ERM A2001 (-4.3A)NoneERM A2001 (-4.3A)ERM A2001 ( 4.8A) | 0.54A | 2y03A-4ib4A:27.6 | 2y03A-4ib4A:28.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y03_B_5FWB601_1 (BETA-1 ADRENERGICRECEPTOR) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 7 / 12 | TRP A 131ASP A 135VAL A 136PHE A 340PHE A 341ASN A 344TYR A 370 | NoneERM A2001 (-3.2A)ERM A2001 (-3.8A)ERM A2001 (-4.3A)NoneERM A2001 (-4.3A)ERM A2001 ( 4.8A) | 0.55A | 2y03B-4ib4A:28.0 | 2y03B-4ib4A:28.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y04_A_68HA601_1 (BETA-1 ADRENERGICRECEPTOR) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 7 / 11 | TRP A 131ASP A 135VAL A 136PHE A 340PHE A 341ASN A 344TYR A 370 | NoneERM A2001 (-3.2A)ERM A2001 (-3.8A)ERM A2001 (-4.3A)NoneERM A2001 (-4.3A)ERM A2001 ( 4.8A) | 0.58A | 2y04A-4ib4A:27.6 | 2y04A-4ib4A:28.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y04_B_68HB601_1 (BETA-1 ADRENERGICRECEPTOR) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 6 / 12 | TRP A 131ASP A 135VAL A 136PHE A 340PHE A 341TYR A 370 | NoneERM A2001 (-3.2A)ERM A2001 (-3.8A)ERM A2001 (-4.3A)NoneERM A2001 ( 4.8A) | 0.59A | 2y04B-4ib4A:28.0 | 2y04B-4ib4A:28.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3D4S_A_TIMA401_1 (BETA-2 ADRENERGICRECEPTOR/T4-LYSOZYMECHIMERA) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 7 / 12 | TRP A 131ASP A 135VAL A 136TRP A 337PHE A 341ASN A 344TYR A 370 | NoneERM A2001 (-3.2A)ERM A2001 (-3.8A)NoneNoneERM A2001 (-4.3A)ERM A2001 ( 4.8A) | 0.58A | 3d4sA-4ib4A:27.7 | 3d4sA-4ib4A:31.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3NYA_A_JTZA1203_1 (BETA-2 ADRENERGICRECEPTOR, LYSOZYME) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 7 / 12 | TRP A 131ASP A 135VAL A 136PHE A 340PHE A 341ASN A 344TYR A 370 | NoneERM A2001 (-3.2A)ERM A2001 (-3.8A)ERM A2001 (-4.3A)NoneERM A2001 (-4.3A)ERM A2001 ( 4.8A) | 0.56A | 3nyaA-4ib4A:27.5 | 3nyaA-4ib4A:31.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3RZE_A_D7VA1201_1 (HISTAMINE H1RECEPTOR, LYSOZYMECHIMERA) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 6 / 12 | ASP A 135SER A 139THR A 140ILE A 143PHE A 341TYR A 370 | ERM A2001 (-3.2A)ERM A2001 (-3.6A)ERM A2001 (-3.9A)NoneNoneERM A2001 ( 4.8A) | 0.75A | 3rzeA-4ib4A:26.7 | 3rzeA-4ib4A:27.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3RZE_A_D7VA1201_1 (HISTAMINE H1RECEPTOR, LYSOZYMECHIMERA) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 6 / 12 | ASP A 135SER A 139THR A 140TRP A 337PHE A 341TYR A 370 | ERM A2001 (-3.2A)ERM A2001 (-3.6A)ERM A2001 (-3.9A)NoneNoneERM A2001 ( 4.8A) | 0.69A | 3rzeA-4ib4A:26.7 | 3rzeA-4ib4A:27.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4AMJ_A_CVDA1359_1 (BETA-1 ADRENERGICRECEPTOR) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 5 / 12 | TRP A 131ASP A 135SER A 222TRP A 337TYR A 370 | NoneERM A2001 (-3.2A)ERM A2001 ( 4.6A)NoneERM A2001 ( 4.8A) | 1.37A | 4amjA-4ib4A:27.8 | 4amjA-4ib4A:28.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4AMJ_A_CVDA1359_1 (BETA-1 ADRENERGICRECEPTOR) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 8 / 12 | TRP A 131ASP A 135VAL A 136TRP A 337PHE A 340PHE A 341ASN A 344TYR A 370 | NoneERM A2001 (-3.2A)ERM A2001 (-3.8A)NoneERM A2001 (-4.3A)NoneERM A2001 (-4.3A)ERM A2001 ( 4.8A) | 0.61A | 4amjA-4ib4A:27.8 | 4amjA-4ib4A:28.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4AMJ_B_CVDB1360_1 (BETA-1 ADRENERGICRECEPTOR) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 5 / 12 | TRP A 131ASP A 135SER A 222TRP A 337TYR A 370 | NoneERM A2001 (-3.2A)ERM A2001 ( 4.6A)NoneERM A2001 ( 4.8A) | 1.38A | 4amjB-4ib4A:28.1 | 4amjB-4ib4A:28.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4AMJ_B_CVDB1360_1 (BETA-1 ADRENERGICRECEPTOR) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 7 / 12 | TRP A 131ASP A 135TRP A 337PHE A 340PHE A 341ASN A 344TYR A 370 | NoneERM A2001 (-3.2A)NoneERM A2001 (-4.3A)NoneERM A2001 (-4.3A)ERM A2001 ( 4.8A) | 0.65A | 4amjB-4ib4A:28.1 | 4amjB-4ib4A:28.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4IAQ_A_2GMA2001_1 (CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 1B AND E.COLI SOLUBLECYTOCHROME B562) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 6 / 12 | LEU A 132ASP A 135ALA A 225TRP A 337PHE A 340PHE A 341 | NoneERM A2001 (-3.2A)ERM A2001 (-3.4A)NoneERM A2001 (-4.3A)None | 0.31A | 4iaqA-4ib4A:33.2 | 4iaqA-4ib4A:49.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4IAQ_A_2GMA2001_1 (CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 1B AND E.COLI SOLUBLECYTOCHROME B562) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 5 / 12 | LEU A 209ALA A 225TRP A 337PHE A 340PHE A 341 | ERM A2001 (-3.7A)ERM A2001 (-3.4A)NoneERM A2001 (-4.3A)None | 1.38A | 4iaqA-4ib4A:33.2 | 4iaqA-4ib4A:49.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4IAR_A_ERMA2001_1 (CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 1B AND E.COLI SOLUBLECYTOCHROME B562) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 5 / 12 | LEU A 132ASP A 135ALA A 225TRP A 337PHE A 340 | NoneERM A2001 (-3.2A)ERM A2001 (-3.4A)NoneERM A2001 (-4.3A) | 0.30A | 4iarA-4ib4A:33.2 | 4iarA-4ib4A:49.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4IAR_A_ERMA2001_2 (CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 1B AND E.COLI SOLUBLECYTOCHROME B562) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 4 / 7 | TRP A 131THR A 140VAL A 208PHE A 341 | NoneERM A2001 (-3.9A)ERM A2001 (-4.0A)None | 0.52A | 4iarA-4ib4A:33.2 | 4iarA-4ib4A:49.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4LDO_A_ALEA1402_1 (LYSOZYME, BETA-2ADRENERGIC RECEPTOR) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 5 / 10 | ASP A 135VAL A 136PHE A 340ASN A 344TYR A 370 | ERM A2001 (-3.2A)ERM A2001 (-3.8A)ERM A2001 (-4.3A)ERM A2001 (-4.3A)ERM A2001 ( 4.8A) | 0.57A | 4ldoA-4ib4A:28.4 | 4ldoA-4ib4A:27.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NC3_A_ERMA1202_1 (CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 12 / 12 | LEU A 132ASP A 135VAL A 136SER A 139VAL A 208PHE A 217MET A 218ALA A 225TRP A 337PHE A 340LEU A 347VAL A 366 | NoneERM A2001 (-3.2A)ERM A2001 (-3.8A)ERM A2001 (-3.6A)ERM A2001 (-4.0A)ERM A2001 (-4.6A)ERM A2001 (-3.7A)ERM A2001 (-3.4A)NoneERM A2001 (-4.3A)ERM A2001 (-4.2A)ERM A2001 ( 4.2A) | 0.24A | 4nc3A-4ib4A:46.7 | 4nc3A-4ib4A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NC3_A_ERMA1202_2 (CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 5 / 6 | LEU A 209ASN A 344GLN A 359LEU A 362GLU A 363 | ERM A2001 (-3.7A)ERM A2001 (-4.3A)NoneERM A2001 ( 4.1A)ERM A2001 ( 4.5A) | 0.65A | 4nc3A-4ib4A:46.7 | 4nc3A-4ib4A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NC3_A_ERMA1202_2 (CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 5 / 6 | THR A 140LEU A 209ASN A 344GLN A 359LEU A 362 | ERM A2001 (-3.9A)ERM A2001 (-3.7A)ERM A2001 (-4.3A)NoneERM A2001 ( 4.1A) | 0.21A | 4nc3A-4ib4A:46.7 | 4nc3A-4ib4A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TUD_A_ERMA2001_1 (5-HYDROXYTRYPTAMINERECEPTOR 2B,SOLUBLECYTOCHROME B562CHIMERA) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 12 / 12 | LEU A 132ASP A 135VAL A 136SER A 139VAL A 208MET A 218ALA A 225PHE A 340PHE A 341LEU A 347LEU A 362VAL A 366 | NoneERM A2001 (-3.2A)ERM A2001 (-3.8A)ERM A2001 (-3.6A)ERM A2001 (-4.0A)ERM A2001 (-3.7A)ERM A2001 (-3.4A)ERM A2001 (-4.3A)NoneERM A2001 (-4.2A)ERM A2001 ( 4.1A)ERM A2001 ( 4.2A) | 0.40A | 5tudA-4ib4A:38.9 | 5tudA-4ib4A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TUD_A_ERMA2001_2 (5-HYDROXYTRYPTAMINERECEPTOR 2B,SOLUBLECYTOCHROME B562CHIMERA) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 5 / 7 | LEU A 209LYS A 211ASN A 344VAL A 348GLU A 363 | ERM A2001 (-3.7A)NoneERM A2001 (-4.3A)ERM A2001 ( 4.9A)ERM A2001 ( 4.5A) | 0.93A | 5tudA-4ib4A:38.9 | 5tudA-4ib4A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TUD_A_ERMA2001_2 (5-HYDROXYTRYPTAMINERECEPTOR 2B,SOLUBLECYTOCHROME B562CHIMERA) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 6 / 7 | THR A 140LEU A 209LYS A 211ASN A 344VAL A 348GLN A 359 | ERM A2001 (-3.9A)ERM A2001 (-3.7A)NoneERM A2001 (-4.3A)ERM A2001 ( 4.9A)None | 0.44A | 5tudA-4ib4A:38.9 | 5tudA-4ib4A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TUD_D_ERMD1201_1 (5-HYDROXYTRYPTAMINERECEPTOR 2B,SOLUBLECYTOCHROME B562CHIMERA) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 12 / 12 | ASP A 135SER A 139VAL A 208MET A 218ALA A 225PHE A 340PHE A 341ASN A 344VAL A 348GLN A 359LEU A 362VAL A 366 | ERM A2001 (-3.2A)ERM A2001 (-3.6A)ERM A2001 (-4.0A)ERM A2001 (-3.7A)ERM A2001 (-3.4A)ERM A2001 (-4.3A)NoneERM A2001 (-4.3A)ERM A2001 ( 4.9A)NoneERM A2001 ( 4.1A)ERM A2001 ( 4.2A) | 0.47A | 5tudD-4ib4A:39.2 | 5tudD-4ib4A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A93_A_8NUA3001_0 (5-HYDROXYTRYPTAMINERECEPTOR 2A,SOLUBLECYTOCHROME B562) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 5 / 12 | LEU A 132PHE A 333TRP A 337PHE A 341TYR A 370 | NoneNoneNoneNoneERM A2001 ( 4.8A) | 1.41A | 6a93A-4ib4A:36.7 | 6a93A-4ib4A:62.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A93_A_8NUA3001_0 (5-HYDROXYTRYPTAMINERECEPTOR 2A,SOLUBLECYTOCHROME B562) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 7 / 12 | TRP A 131SER A 139THR A 140ILE A 143PHE A 340PHE A 341TYR A 370 | NoneERM A2001 (-3.6A)ERM A2001 (-3.9A)NoneERM A2001 (-4.3A)NoneERM A2001 ( 4.8A) | 0.73A | 6a93A-4ib4A:36.7 | 6a93A-4ib4A:62.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A93_A_8NUA3001_0 (5-HYDROXYTRYPTAMINERECEPTOR 2A,SOLUBLECYTOCHROME B562) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 8 / 12 | TRP A 131SER A 139THR A 140TRP A 337PHE A 340PHE A 341LEU A 362TYR A 370 | NoneERM A2001 (-3.6A)ERM A2001 (-3.9A)NoneERM A2001 (-4.3A)NoneERM A2001 ( 4.1A)ERM A2001 ( 4.8A) | 0.76A | 6a93A-4ib4A:36.7 | 6a93A-4ib4A:62.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A93_A_8NUA3001_0 (5-HYDROXYTRYPTAMINERECEPTOR 2A,SOLUBLECYTOCHROME B562) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 7 / 12 | TRP A 131THR A 140ILE A 143PHE A 333PHE A 340PHE A 341TYR A 370 | NoneERM A2001 (-3.9A)NoneNoneERM A2001 (-4.3A)NoneERM A2001 ( 4.8A) | 0.90A | 6a93A-4ib4A:36.7 | 6a93A-4ib4A:62.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A93_A_8NUA3001_0 (5-HYDROXYTRYPTAMINERECEPTOR 2A,SOLUBLECYTOCHROME B562) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 8 / 12 | TRP A 131THR A 140PHE A 333TRP A 337PHE A 340PHE A 341LEU A 362TYR A 370 | NoneERM A2001 (-3.9A)NoneNoneERM A2001 (-4.3A)NoneERM A2001 ( 4.1A)ERM A2001 ( 4.8A) | 0.86A | 6a93A-4ib4A:36.7 | 6a93A-4ib4A:62.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A93_B_8NUB3001_0 (5-HYDROXYTRYPTAMINERECEPTOR 2A,SOLUBLECYTOCHROME B562) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 7 / 12 | TRP A 131VAL A 136SER A 139THR A 140PHE A 340PHE A 341VAL A 366 | NoneERM A2001 (-3.8A)ERM A2001 (-3.6A)ERM A2001 (-3.9A)ERM A2001 (-4.3A)NoneERM A2001 ( 4.2A) | 0.73A | 6a93B-4ib4A:36.2 | 6a93B-4ib4A:62.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A93_B_8NUB3001_0 (5-HYDROXYTRYPTAMINERECEPTOR 2A,SOLUBLECYTOCHROME B562) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 8 / 12 | TRP A 131VAL A 136SER A 139TRP A 337PHE A 340PHE A 341LEU A 362VAL A 366 | NoneERM A2001 (-3.8A)ERM A2001 (-3.6A)NoneERM A2001 (-4.3A)NoneERM A2001 ( 4.1A)ERM A2001 ( 4.2A) | 0.82A | 6a93B-4ib4A:36.2 | 6a93B-4ib4A:62.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A94_A_ZOTA3001_0 (5-HYDROXYTRYPTAMINERECEPTOR 2A,SOLUBLECYTOCHROME B562) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 6 / 12 | PHE A 333TRP A 337PHE A 340PHE A 341ASN A 344VAL A 366 | NoneNoneERM A2001 (-4.3A)NoneERM A2001 (-4.3A)ERM A2001 ( 4.2A) | 0.72A | 6a94A-4ib4A:36.7 | 6a94A-4ib4A:62.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A94_A_ZOTA3001_0 (5-HYDROXYTRYPTAMINERECEPTOR 2A,SOLUBLECYTOCHROME B562) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 7 / 12 | SER A 139GLY A 221TRP A 337PHE A 340PHE A 341ASN A 344VAL A 366 | ERM A2001 (-3.6A)ERM A2001 ( 4.3A)NoneERM A2001 (-4.3A)NoneERM A2001 (-4.3A)ERM A2001 ( 4.2A) | 0.78A | 6a94A-4ib4A:36.7 | 6a94A-4ib4A:62.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A94_A_ZOTA3001_0 (5-HYDROXYTRYPTAMINERECEPTOR 2A,SOLUBLECYTOCHROME B562) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 7 / 12 | TRP A 131SER A 139GLY A 221PHE A 340PHE A 341ASN A 344VAL A 366 | NoneERM A2001 (-3.6A)ERM A2001 ( 4.3A)ERM A2001 (-4.3A)NoneERM A2001 (-4.3A)ERM A2001 ( 4.2A) | 0.82A | 6a94A-4ib4A:36.7 | 6a94A-4ib4A:62.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A94_A_ZOTA3001_0 (5-HYDROXYTRYPTAMINERECEPTOR 2A,SOLUBLECYTOCHROME B562) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 5 / 12 | TRP A 131SER A 139LEU A 209PHE A 340VAL A 366 | NoneERM A2001 (-3.6A)ERM A2001 (-3.7A)ERM A2001 (-4.3A)ERM A2001 ( 4.2A) | 1.04A | 6a94A-4ib4A:36.7 | 6a94A-4ib4A:62.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A94_B_ZOTB3001_0 (5-HYDROXYTRYPTAMINERECEPTOR 2A,SOLUBLECYTOCHROME B562) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 5 / 12 | PHE A 333TRP A 337PHE A 340PHE A 341VAL A 366 | NoneNoneERM A2001 (-4.3A)NoneERM A2001 ( 4.2A) | 0.67A | 6a94B-4ib4A:36.3 | 6a94B-4ib4A:62.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A94_B_ZOTB3001_0 (5-HYDROXYTRYPTAMINERECEPTOR 2A,SOLUBLECYTOCHROME B562) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 5 / 12 | THR A 140PHE A 333TRP A 337PHE A 341VAL A 366 | ERM A2001 (-3.9A)NoneNoneNoneERM A2001 ( 4.2A) | 1.11A | 6a94B-4ib4A:36.3 | 6a94B-4ib4A:62.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A94_B_ZOTB3001_0 (5-HYDROXYTRYPTAMINERECEPTOR 2A,SOLUBLECYTOCHROME B562) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 7 / 12 | VAL A 136SER A 139GLY A 221TRP A 337PHE A 340PHE A 341VAL A 366 | ERM A2001 (-3.8A)ERM A2001 (-3.6A)ERM A2001 ( 4.3A)NoneERM A2001 (-4.3A)NoneERM A2001 ( 4.2A) | 0.75A | 6a94B-4ib4A:36.3 | 6a94B-4ib4A:62.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A94_B_ZOTB3001_0 (5-HYDROXYTRYPTAMINERECEPTOR 2A,SOLUBLECYTOCHROME B562) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 5 / 12 | VAL A 136SER A 139LEU A 209PHE A 340VAL A 366 | ERM A2001 (-3.8A)ERM A2001 (-3.6A)ERM A2001 (-3.7A)ERM A2001 (-4.3A)ERM A2001 ( 4.2A) | 0.98A | 6a94B-4ib4A:36.3 | 6a94B-4ib4A:62.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A94_B_ZOTB3001_0 (5-HYDROXYTRYPTAMINERECEPTOR 2A,SOLUBLECYTOCHROME B562) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 7 / 12 | VAL A 136SER A 139THR A 140GLY A 221TRP A 337PHE A 341VAL A 366 | ERM A2001 (-3.8A)ERM A2001 (-3.6A)ERM A2001 (-3.9A)ERM A2001 ( 4.3A)NoneNoneERM A2001 ( 4.2A) | 0.88A | 6a94B-4ib4A:36.3 | 6a94B-4ib4A:62.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A94_B_ZOTB3001_0 (5-HYDROXYTRYPTAMINERECEPTOR 2A,SOLUBLECYTOCHROME B562) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 5 / 12 | VAL A 136SER A 139THR A 140LEU A 209PHE A 340 | ERM A2001 (-3.8A)ERM A2001 (-3.6A)ERM A2001 (-3.9A)ERM A2001 (-3.7A)ERM A2001 (-4.3A) | 0.92A | 6a94B-4ib4A:36.3 | 6a94B-4ib4A:62.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6A94_B_ZOTB3001_0 (5-HYDROXYTRYPTAMINERECEPTOR 2A,SOLUBLECYTOCHROME B562) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 5 / 12 | VAL A 136SER A 139THR A 140LEU A 209VAL A 366 | ERM A2001 (-3.8A)ERM A2001 (-3.6A)ERM A2001 (-3.9A)ERM A2001 (-3.7A)ERM A2001 ( 4.2A) | 0.98A | 6a94B-4ib4A:36.3 | 6a94B-4ib4A:62.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6BQG_A_ERMA1201_1 (5-HYDROXYTRYPTAMINERECEPTOR 2C,SOLUBLECYTOCHROME B562) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 7 / 12 | ASP A 135SER A 139GLY A 221ALA A 225PHE A 340ASN A 344VAL A 366 | ERM A2001 (-3.2A)ERM A2001 (-3.6A)ERM A2001 ( 4.3A)ERM A2001 (-3.4A)ERM A2001 (-4.3A)ERM A2001 (-4.3A)ERM A2001 ( 4.2A) | 0.44A | 6bqgA-4ib4A:36.4 | 6bqgA-4ib4A:62.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6BQG_A_ERMA1201_1 (5-HYDROXYTRYPTAMINERECEPTOR 2C,SOLUBLECYTOCHROME B562) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 7 / 12 | ASP A 135SER A 139VAL A 208GLY A 221ALA A 225PHE A 340VAL A 366 | ERM A2001 (-3.2A)ERM A2001 (-3.6A)ERM A2001 (-4.0A)ERM A2001 ( 4.3A)ERM A2001 (-3.4A)ERM A2001 (-4.3A)ERM A2001 ( 4.2A) | 0.48A | 6bqgA-4ib4A:36.4 | 6bqgA-4ib4A:62.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6BQG_A_ERMA1201_2 (5-HYDROXYTRYPTAMINERECEPTOR 2C,SOLUBLECYTOCHROME B562) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 5 / 5 | VAL A 136THR A 140LEU A 209VAL A 348LEU A 362 | ERM A2001 (-3.8A)ERM A2001 (-3.9A)ERM A2001 (-3.7A)ERM A2001 ( 4.9A)ERM A2001 ( 4.1A) | 0.73A | 6bqgA-4ib4A:36.4 | 6bqgA-4ib4A:62.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6CM4_A_8NUA2001_0 (D(2) DOPAMINERECEPTOR, ENDOLYSINCHIMERA) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 6 / 12 | VAL A 136THR A 140PHE A 333TRP A 337PHE A 341TYR A 370 | ERM A2001 (-3.8A)ERM A2001 (-3.9A)NoneNoneNoneERM A2001 ( 4.8A) | 1.03A | 6cm4A-4ib4A:26.9 | 6cm4A-4ib4A:30.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6DRX_A_H8GA1201_0 (5HT2B RECEPTOR, BRILCHIMERA) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 12 / 12 | TRP A 131LEU A 132VAL A 136SER A 139THR A 140PHE A 217ALA A 225TRP A 337PHE A 340ASN A 344VAL A 366TYR A 370 | NoneNoneERM A2001 (-3.8A)ERM A2001 (-3.6A)ERM A2001 (-3.9A)ERM A2001 (-4.6A)ERM A2001 (-3.4A)NoneERM A2001 (-4.3A)ERM A2001 (-4.3A)ERM A2001 ( 4.2A)ERM A2001 ( 4.8A) | 0.38A | 6drxA-4ib4A:46.2 | 6drxA-4ib4A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6DRX_A_H8GA1201_0 (5HT2B RECEPTOR, BRILCHIMERA) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 5 / 12 | VAL A 136SER A 139PHE A 217TRP A 337PHE A 341 | ERM A2001 (-3.8A)ERM A2001 (-3.6A)ERM A2001 (-4.6A)NoneNone | 1.45A | 6drxA-4ib4A:46.2 | 6drxA-4ib4A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6DRY_A_H8DA2001_0 (5HT2B RECEPTOR, BRILCHIMERA) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 10 / 11 | ASP A 135VAL A 136SER A 139THR A 140VAL A 208LEU A 209ALA A 225PHE A 340VAL A 366TYR A 370 | ERM A2001 (-3.2A)ERM A2001 (-3.8A)ERM A2001 (-3.6A)ERM A2001 (-3.9A)ERM A2001 (-4.0A)ERM A2001 (-3.7A)ERM A2001 (-3.4A)ERM A2001 (-4.3A)ERM A2001 ( 4.2A)ERM A2001 ( 4.8A) | 0.41A | 6dryA-4ib4A:44.5 | 6dryA-4ib4A:99.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6DRZ_A_H8JA1206_0 (5HT2B RECEPTOR, BRILCHIMERA) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 5 / 12 | VAL A 136SER A 139LEU A 209PHE A 217PHE A 340 | ERM A2001 (-3.8A)ERM A2001 (-3.6A)ERM A2001 (-3.7A)ERM A2001 (-4.6A)ERM A2001 (-4.3A) | 1.12A | 6drzA-4ib4A:43.7 | 6drzA-4ib4A:99.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6DRZ_A_H8JA1206_0 (5HT2B RECEPTOR, BRILCHIMERA) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 11 / 12 | VAL A 136SER A 139THR A 140VAL A 208LEU A 209PHE A 217PHE A 340PHE A 341ASN A 344VAL A 366TYR A 370 | ERM A2001 (-3.8A)ERM A2001 (-3.6A)ERM A2001 (-3.9A)ERM A2001 (-4.0A)ERM A2001 (-3.7A)ERM A2001 (-4.6A)ERM A2001 (-4.3A)NoneERM A2001 (-4.3A)ERM A2001 ( 4.2A)ERM A2001 ( 4.8A) | 0.55A | 6drzA-4ib4A:43.7 | 6drzA-4ib4A:99.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6H7J_A_5FWA401_0 (BETA-1 ADRENERGICRECEPTOR) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 5 / 12 | TRP A 131ASP A 135SER A 222ASN A 344TYR A 370 | NoneERM A2001 (-3.2A)ERM A2001 ( 4.6A)ERM A2001 (-4.3A)ERM A2001 ( 4.8A) | 1.26A | 6h7jA-4ib4A:27.8 | 6h7jA-4ib4A:10.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6H7J_A_5FWA401_0 (BETA-1 ADRENERGICRECEPTOR) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 8 / 12 | TRP A 131ASP A 135VAL A 136SER A 222PHE A 340PHE A 341ASN A 344TYR A 370 | NoneERM A2001 (-3.2A)ERM A2001 (-3.8A)ERM A2001 ( 4.6A)ERM A2001 (-4.3A)NoneERM A2001 (-4.3A)ERM A2001 ( 4.8A) | 0.53A | 6h7jA-4ib4A:27.8 | 6h7jA-4ib4A:10.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6H7J_B_5FWB402_0 (BETA-1 ADRENERGICRECEPTOR) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 8 / 12 | TRP A 131ASP A 135VAL A 136SER A 222PHE A 340PHE A 341ASN A 344TYR A 370 | NoneERM A2001 (-3.2A)ERM A2001 (-3.8A)ERM A2001 ( 4.6A)ERM A2001 (-4.3A)NoneERM A2001 (-4.3A)ERM A2001 ( 4.8A) | 0.53A | 6h7jB-4ib4A:28.2 | 6h7jB-4ib4A:10.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6H7L_A_Y00A406_0 (BETA-1 ADRENERGICRECEPTOR) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 6 / 12 | TRP A 131ASP A 135SER A 222ASN A 344TRP A 367TYR A 370 | NoneERM A2001 (-3.2A)ERM A2001 ( 4.6A)ERM A2001 (-4.3A)NoneERM A2001 ( 4.8A) | 1.20A | 6h7lA-4ib4A:28.0 | 6h7lA-4ib4A:10.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6H7L_A_Y00A406_0 (BETA-1 ADRENERGICRECEPTOR) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 6 / 12 | TRP A 131ASP A 135VAL A 136ASN A 344TRP A 367TYR A 370 | NoneERM A2001 (-3.2A)ERM A2001 (-3.8A)ERM A2001 (-4.3A)NoneERM A2001 ( 4.8A) | 0.54A | 6h7lA-4ib4A:28.0 | 6h7lA-4ib4A:10.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6H7L_B_Y00B405_0 (BETA-1 ADRENERGICRECEPTOR) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 6 / 12 | TRP A 131ASP A 135SER A 222ASN A 344TRP A 367TYR A 370 | NoneERM A2001 (-3.2A)ERM A2001 ( 4.6A)ERM A2001 (-4.3A)NoneERM A2001 ( 4.8A) | 1.23A | 6h7lB-4ib4A:28.1 | 6h7lB-4ib4A:10.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6H7L_B_Y00B405_0 (BETA-1 ADRENERGICRECEPTOR) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 6 / 12 | TRP A 131ASP A 135VAL A 136ASN A 344TRP A 367TYR A 370 | NoneERM A2001 (-3.2A)ERM A2001 (-3.8A)ERM A2001 (-4.3A)NoneERM A2001 ( 4.8A) | 0.55A | 6h7lB-4ib4A:28.1 | 6h7lB-4ib4A:10.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6H7M_A_68HA504_0 (BETA-1 ADRENERGICRECEPTOR) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 5 / 12 | TRP A 131ASP A 135SER A 222ASN A 344TYR A 370 | NoneERM A2001 (-3.2A)ERM A2001 ( 4.6A)ERM A2001 (-4.3A)ERM A2001 ( 4.8A) | 1.16A | 6h7mA-4ib4A:28.0 | 6h7mA-4ib4A:10.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6H7M_A_68HA504_0 (BETA-1 ADRENERGICRECEPTOR) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 7 / 12 | TRP A 131ASP A 135VAL A 136PHE A 340PHE A 341ASN A 344TYR A 370 | NoneERM A2001 (-3.2A)ERM A2001 (-3.8A)ERM A2001 (-4.3A)NoneERM A2001 (-4.3A)ERM A2001 ( 4.8A) | 0.45A | 6h7mA-4ib4A:28.0 | 6h7mA-4ib4A:10.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6H7M_B_68HB405_0 (BETA-1 ADRENERGICRECEPTOR) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 7 / 12 | TRP A 131ASP A 135VAL A 136PHE A 340PHE A 341ASN A 344TYR A 370 | NoneERM A2001 (-3.2A)ERM A2001 (-3.8A)ERM A2001 (-4.3A)NoneERM A2001 (-4.3A)ERM A2001 ( 4.8A) | 0.44A | 6h7mB-4ib4A:28.2 | 6h7mB-4ib4A:10.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6IBL_A_H98A501_0 (THIOREDOXIN 1,BETA-1ADRENERGIC RECEPTOR) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 7 / 12 | TRP A 131VAL A 136TRP A 337PHE A 340PHE A 341ASN A 344TYR A 370 | NoneERM A2001 (-3.8A)NoneERM A2001 (-4.3A)NoneERM A2001 (-4.3A)ERM A2001 ( 4.8A) | 0.47A | 6iblA-4ib4A:28.0 | 6iblA-4ib4A:26.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6IBL_B_H98B501_0 (THIOREDOXIN 1,BETA-1ADRENERGIC RECEPTOR) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 7 / 12 | TRP A 131VAL A 136TRP A 337PHE A 340PHE A 341ASN A 344TYR A 370 | NoneERM A2001 (-3.8A)NoneERM A2001 (-4.3A)NoneERM A2001 (-4.3A)ERM A2001 ( 4.8A) | 0.48A | 6iblB-4ib4A:28.1 | 6iblB-4ib4A:26.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MXT_A_K5YA1401_0 (ENDOLYSIN, BETA-2ADRENERGIC RECEPTORCHIMERA) |
4ib4 | CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562 (Escherichiacoli;Homosapiens) | 5 / 12 | TRP A 131VAL A 136PHE A 340ASN A 344TYR A 370 | NoneERM A2001 (-3.8A)ERM A2001 (-4.3A)ERM A2001 (-4.3A)ERM A2001 ( 4.8A) | 0.59A | 6mxtA-4ib4A:28.4 | 6mxtA-4ib4A:25.39 |